Research output per year
Research output per year
Personal profile
Education/Academic qualification
Ciências da Saúde -Genética, Doctorate, NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Award Date: 1 Jul 2001
Ciências da Saúde - Medicina, Master, Universidade de Lisboa
Award Date: 1 Jul 1987
Fingerprint
Dive into the research topics where Joaquim Calado is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cysteine as a Multifaceted Player in Kidney, the Cysteine-Related Thiolome and Its Implications for Precision Medicine
Correia, M. J., Pimpão, A. B., Fernandes, D. G. F., Morello, J., Sequeira, C. O., Calado, J., Antunes, A. M. M., Almeida, M. S., Branco, P., Monteiro, E. C., Vicente, J. B., Serpa, J. & Pereira, S. A., 1 Feb 2022, In: Molecules. 27, 4, 1416.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Zebrafish model as a screen to prevent cyst inflation in autosomal dominant polycystic kidney disease
Oliveira, I., Jacinto, R., Pestana, S., Nolasco, F., Calado, J., Lopes, S. S. & Roxo-Rosa, M., 2 Aug 2021, In: International Journal of Molecular Sciences. 22, 16, 9013.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations
Kidd, K., Vylet'al, P., Schaeffer, C., Olinger, E., Živná, M., Hodaňová, K., Robins, V., Johnson, E., Taylor, A., Martin, L., Izzi, C., Jorge, S. C., Calado, J., Torres, R. J., Lhotta, K., Steubl, D., Gale, D. P., Gast, C., Gombos, E., Ainsworth, H. C. & 22 others, , Sep 2020, In: Kidney International Reports. 5, 9, p. 1472-1485 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile5 Citations (Scopus)4 Downloads (Pure) -
Efeito da empagliflozina para além do controlo glicémico: benefício cardiovascular em doentes com DMT2 e doença cardiovascular estabelecida
Translated title of the contribution :Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in patients with type 2 diabetes and established cardiovascular disease Research output: Contribution to journal › Review article › peer-review
1 Citation (Scopus) -
The Na+-coupled glucose transporter SGLT2 interacts with its accessory unit MAP17 in vitro and their expressions overlap in the renal proximal tubule
Calado, J., Santos, A. R., Aires, I., Lebre, F., Nolasco, F., Rueff, J. & Ramalho, J., Oct 2018, In: FEBS Letters. 592, 19, p. 3317-3326Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus)